Marius C. Hoener
Marius C. Hoener
Ph.D., Distinguished Scientist, Head of Exploratory Biology, Drug Discovery Project Team Leader
Verified email at roche.com
Title
Cited by
Cited by
Year
Pharmacological characterization of designer cathinones in vitro
LD Simmler, TA Buser, M Donzelli, Y Schramm, LH Dieu, J Huwyler, ...
British journal of pharmacology 168 (2), 458-470, 2013
5522013
Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of α-synuclein, parkin, and DJ-1 in Caenorhabditis elegans
R Ved, S Saha, B Westlund, C Perier, L Burnam, A Sluder, M Hoener, ...
Journal of Biological Chemistry 280 (52), 42655-42668, 2005
2712005
A renaissance in trace amines inspired by a novel GPCR family
L Lindemann, MC Hoener
Trends in pharmacological sciences 26 (5), 274-281, 2005
2662005
Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors
L Lindemann, M Ebeling, NA Kratochwil, JR Bunzow, DK Grandy, ...
Genomics 85 (3), 372-385, 2005
2492005
Trace amine-associated receptor 1 modulates dopaminergic activity
L Lindemann, CA Meyer, K Jeanneau, A Bradaia, L Ozmen, ...
Journal of Pharmacology and Experimental Therapeutics 324 (3), 948-956, 2008
2322008
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity
FG Revel, JL Moreau, RR Gainetdinov, A Bradaia, TD Sotnikova, R Mory, ...
Proceedings of the national academy of sciences 108 (20), 8485-8490, 2011
2142011
Caenorhabditis elegans MPP+ model of Parkinson’s disease for high-throughput drug screenings
E Braungart, M Gerlach, P Riederer, R Baumeister, MC Hoener
Neurodegenerative diseases 1 (4-5), 175-183, 2004
1802004
Monoamine transporter and receptor interaction profiles of a new series of designer cathinones
LD Simmler, A Rickli, MC Hoener, ME Liechti
Neuropharmacology 79, 152-160, 2014
1672014
The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system
A Bradaia, G Trube, H Stalder, RD Norcross, L Ozmen, JG Wettstein, ...
Proceedings of the National Academy of Sciences 106 (47), 20081-20086, 2009
1542009
A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic-and antidepressant-like activity, improve cognition and control body weight
FG Revel, JL Moreau, B Pouzet, R Mory, A Bradaia, D Buchy, V Metzler, ...
Molecular psychiatry 18 (5), 543-556, 2013
1512013
Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones
A Rickli, MC Hoener, ME Liechti
European Neuropsychopharmacology 25 (3), 365-376, 2015
1422015
The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA (“ecstasy”) in humans
CM Hysek, LD Simmler, M Ineichen, E Grouzmann, MC Hoener, ...
Clinical pharmacology & therapeutics 90 (2), 246-255, 2011
1382011
Are there differences between the secretion characteristics of NGF and BDNF? Implications for the modulatory role of neurotrophins in activity‐dependent neuronal plasticity
O Griesbeck, M Canossa, G Campana, A Gärtner, MC Hoener, H Nawa, ...
Microscopy research and technique 45 (4‐5), 262-275, 1999
1331999
Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study
CM Hysek, LD Simmler, VG Nicola, N Vischer, M Donzelli, S Krähenbühl, ...
PloS one 7 (5), e36476, 2012
1322012
Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2, 5-dimethoxy-substituted phenethylamines (2C drugs)
A Rickli, D Luethi, J Reinisch, D Buchy, MC Hoener, ME Liechti
Neuropharmacology 99, 546-553, 2015
1062015
Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics
FG Revel, JL Moreau, RR Gainetdinov, A Ferragud, ...
Biological psychiatry 72 (11), 934-942, 2012
1012012
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
A Rickli, OD Moning, MC Hoener, ME Liechti
European Neuropsychopharmacology 26 (8), 1327-1337, 2016
1002016
Trace amines and their receptors
RR Gainetdinov, MC Hoener, MD Berry
Pharmacological reviews 70 (3), 549-620, 2018
962018
The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf+/− heterozygous null mice
JSO Lindholm, H Autio, L Vesa, H Antila, L Lindemann, MC Hoener, ...
Neuropharmacology 62 (1), 391-397, 2012
922012
Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors
D Leo, L Mus, S Espinoza, MC Hoener, TD Sotnikova, RR Gainetdinov
Neuropharmacology 81, 283-291, 2014
862014
The system can't perform the operation now. Try again later.
Articles 1–20